UTMD
UTAH MEDICAL PRODUCTS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$73.96
−0.31%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$74.25
From 52W high−0.90%
Volume42344.00
Market cap$235.48M
P/E (TTM)22.5x
P/S (TTM)6.5x
Div yield1.26%
Key dataSep 18, 2026
Open
$74.25
From 52W high
−0.90%
Volume
42344.00
Market cap
$235.48M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
10.1x
P/E (TTM)
22.5x
RSI (14)
61.4
MomentumView details →
1D Return
−0.31%
YTD Return
+32.45%
SummaryUpdated Jun 1, 2026
Utah Medical Products, Inc. (NASDAQ:UTMD) is a specialized medical device manufacturer founded in 1978 and headquartered in Midvale, Utah. The company went public in 1999 and has established itself as a niche player in the medical instruments and supplies industry, focusing primarily on women's health, neonatal care, and critical care medical devices. UTMD operates as a small-cap healthcare company that develops, manufactures, and distributes specialized medical devices primarily for hospital use, with a particular emphasis on labor and delivery, gynecological procedures, and neonatal intensive care applications.
Similar companies
Latest newsMore news →
Utah Medical Products, Inc. announced a self-tender offer to repurchase up to 650,000 of its shares, about 20% of shares outstanding, at $75.00 per share, with tenders due by October 7, 2026.5d agoUtah Medical Products, Inc. announced that its Board of Directors approved a quarterly cash dividend of $0.31 per share, payable on October 5, 2026, to stockholders of record on September 17, 2026.47d agoUtah Medical Products, Inc. reported its financial results for the second calendar quarter and first half of 2026, showing a continued decline in overall revenues compared to the same periods in 2025.59d ago